In 2024, the U.S. Drug Enforcement Administration (DEA) indicated that they plan to reclassify marijuana for a Plan III drug. This rescheduling will understand that cannabis has legitimate healthcare reasons and will help open up the doorway to exploration on other prospective therapy makes use